|
⚲
|
| Keyboard |
| Khosla Rachna
✚
|
|
|---|---|
| CIK # | 0001881332 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001881332] | |
| 4 | [0001881332] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Khosla Rachna | |
| Amgen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amgen Inc AMGN
Common Stock
|
2026-03-16 | Tax withheld | 707 | $366.21 | 258,910 |
|
Amgen Inc AMGN
Common Stock
|
2026-03-03 | Grant | 1,876 | $0.00 | |
|
Amgen Inc AMGN
Common Stock
|
2025-11-12 | Sell | 890 | $336.24 | 299,254 |
|
Amgen Inc AMGN
Common Stock
|
2025-11-05 | Tax withheld | 226 | $296.70 | 67,054 |
|
Amgen Inc AMGN
Common Stock
|
2025-06-05 | Sell | 1,500 | $289.68 | 434,520 |
|
Amgen Inc AMGN
Nqso (Right to Buy) · derivative
|
2025-05-06 | Grant | 3,943 | $270.44 | 1,066,345 |
|
Amgen Inc AMGN
Common Stock
|
2025-05-06 | Grant | 610 | $0.00 | |
|
Amgen Inc AMGN
Common Stock
|
2025-05-02 | Tax withheld | 110 | $283.78 | 31,216 |
|
Amgen Inc AMGN
Common Stock
|
2025-05-02 | Tax withheld | 104 | $283.78 | 29,513 |
|
Amgen Inc AMGN
Common Stock
|
2025-04-30 | Tax withheld | 74 | $288.56 | 21,353 |
|
Amgen Inc AMGN
Common Stock
|
2025-03-17 | Tax withheld | 489 | $313.71 | 153,404 |
|
Amgen Inc AMGN
Common Stock
|
2025-03-03 | Grant | 1,403 | $0.00 | |
|
Amgen Inc AMGN
Common Stock
|
2024-11-05 | Tax withheld | 212 | $316.91 | 67,185 |
|
Amgen Inc AMGN
Nqso (Right to Buy) · derivative
|
2024-05-07 | Grant | 3,461 | $300.30 | 1,039,338 |
|
Amgen Inc AMGN
Common Stock
|
2024-05-07 | Grant | 532 | $0.00 | |
|
Amgen Inc AMGN
Common Stock
|
2024-05-05 | Tax withheld | 41 | $311.29 | 12,763 |
|
Amgen Inc AMGN
Common Stock
|
2024-05-02 | Tax withheld | 74 | $277.37 | 20,525 |
|
Amgen Inc AMGN
Common Stock
|
2024-04-30 | Tax withheld | 48 | $276.38 | 13,266 |
|
Amgen Inc AMGN
Common Stock
|
2024-03-18 | Tax withheld | 438 | $268.87 | 117,765 |
|
Amgen Inc AMGN
Common Stock
|
2024-03-06 | Grant | 1,256 | $0.00 | |
| showing 20 of 41 most recent transactions | |||||